These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9804710)

  • 1. Nicotine replacement therapy for a healthier nation. Nicotine replacement is cost effective and should be prescribable on the NHS.
    Smeeth L; Fowler G
    BMJ; 1998 Nov; 317(7168):1266-7. PubMed ID: 9804710
    [No Abstract]   [Full Text] [Related]  

  • 2. Be wary of subsidising nicotine replacement therapy.
    Miller C; Kriven S; Rowley D; Abram L
    Tob Control; 2002 Dec; 11(4):380-1. PubMed ID: 12432167
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
    Stapleton JA; Lowin A; Russell MA
    Lancet; 1999 Jul; 354(9174):210-5. PubMed ID: 10421303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
    Bolin K; Wilson K; Benhaddi H; de Nigris E; Marbaix S; Mork AC; Aubin HJ
    Eur J Public Health; 2009 Dec; 19(6):650-4. PubMed ID: 19491286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The demand for nicotine replacement therapies.
    Tauras JA; Chaloupka FJ
    Nicotine Tob Res; 2003 Apr; 5(2):237-43. PubMed ID: 12745497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsidised nicotine replacement therapy.
    Grigg M; Glasgow H
    Tob Control; 2003 Jun; 12(2):238-9. PubMed ID: 12773740
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised trial of two nicotine patch protocols distributed through a state quitline.
    Burns EK; Hood NE; Goforth E; Levinson AH
    Tob Control; 2016 Mar; 25(2):218-23. PubMed ID: 25416755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine replacement therapy should be prescribable on NHS.
    Fowler G
    BMJ; 1997 Jun; 314(7097):1827. PubMed ID: 9224091
    [No Abstract]   [Full Text] [Related]  

  • 11. Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial.
    Walker N; Howe C; Bullen C; Grigg M; Glover M; McRobbie H; Laugesen M; Jiang J; Chen MH; Whittaker R; Rodgers A
    Addiction; 2011 Jun; 106(6):1176-85. PubMed ID: 21371155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis.
    Etter JF; Burri M; Stapleton J
    Addiction; 2007 May; 102(5):815-22. PubMed ID: 17493109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefits of switching smoking cessation drugs to over-the-counter status.
    Keeler TE; Hu TW; Keith A; Manning R; Marciniak MD; Ong M; Sung HY
    Health Econ; 2002 Jul; 11(5):389-402. PubMed ID: 12112489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
    Nielsen K; Fiore MC
    Prev Med; 2000 Mar; 30(3):209-16. PubMed ID: 10684744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should managed care organizations pay for nicotine replacement therapy?
    Westman EC
    Am J Manag Care; 1997 Feb; 3(2):335-7. PubMed ID: 10169267
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine replacement therapy in pregnancy: use or avoid?
    Coleman T
    J R Soc Promot Health; 2005 Sep; 125(5):210-1. PubMed ID: 16220731
    [No Abstract]   [Full Text] [Related]  

  • 17. Should smoking cessation cost a packet? A pilot randomized controlled trial of the cost-effectiveness of distributing nicotine therapy free of charge.
    Dey P; Foy R; Woodman M; Fullard B; Gibbs A
    Br J Gen Pract; 1999 Feb; 49(439):127-8. PubMed ID: 10326267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine replacement therapy in smoking cessation.
    Campbell I
    Thorax; 2003 Jun; 58(6):464-5. PubMed ID: 12775853
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal nicotine replacement smoking cessation therapy.
    Setter SM; Johnson MD
    Ann Pharmacother; 1998 Feb; 32(2):264-6. PubMed ID: 9496414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.